Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal Puncture Device received 510(k) clearance from the FDA. Transseptal puncture is designed to enable access to...
Jonathan Menkes Comments on Sports Trademark Trends and Generative AI in World Intellectual Property Review
In a recent interview with World Intellectual Property Review, Knobbe Martens Trademark and Brand Protection partner Jonathan Menkes, Co-Chair of the firm’s Sports and Gaming practice, shared insights on the...
Stryker Provides Update After Cyberattack
According to a press release, Stryker Corporation recently “experienced a cybersecurity attack which resulted in a global disruption to Stryker’s (internal, corporate) Microsoft environment.” A cyberterrorist organization, Handala, reportedly claimed responsibility...